GlassScriptPhysician profile
Kyle Shinichi Yang
NPI 1730521501
$38,567.23
in general payments reported to CMS, 2019-2025
25 companies · $3,614 in 2025
The $3,614 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $3,877 · 2021: $2,455 · 2022: $3,897 · 2023: $3,320 · 2024: $2,774 · 2025: $3,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,667 · Education: $41.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,666.72 |
| Education | $41.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $20,340.57 | 2019-2020 | |
| Boston Scientific Corporation | $5,931.26 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $5,808.66 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Abbott Laboratories | $1,268.68 | 2019-2025 | Eterna, Proclaim |
| Nalu Medical, INC. | $703.63 | 2022-2023 | Nalu Neurostimulation System |
| Stryker Corporation | $597.29 | 2019-2025 | Mild Device Kit, Omnicurve, Optablate |
| Nevro Corp. | $459.88 | 2021-2024 | Senza |
| Allergan, INC. | $425.64 | 2019 | |
| Painteq LLC | $392.50 | 2022-2023 | Painteq |
| Spr Therapeutics, INC | $351.46 | 2020-2025 | Sprint Pns System |
| Curonix LLC | $304.78 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $278.47 | 2020-2022 | |
| Avanos Medical | $216.67 | 2020-2021 | |
| Integra Lifesciences Corporation | $209.01 | 2021 | |
| Team_makena_llc | $208.50 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $152.55 | 2021 | |
| Innovation Technologies INC | $150.90 | 2024 | Irrisept |
| Vertos Medical, INC. | $136.58 | 2022 | |
| Abbvie INC. | $124.99 | 2023 | Skyrizi |
| Relievant Medsystems, INC. | $117.97 | 2022 | |
| Saluda Medical Americas, INC. | $116.20 | 2025 | Evoke |
| Teva Pharmaceuticals USA, INC. | $111.26 | 2019 | |
| Spinal Simplicity, LLC | $90.84 | 2021 | |
| Depuy Synthes Sales INC. | $44.14 | 2019 | |
| Pacira Therapeutics, INC. | $24.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.